Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Esophageal Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Digestive System Neoplasm
Esophageal Neoplasm

Cancer Family

Esophageal Neoplasm

CI-CAN-00000174Explore in graph →

Non-malignant555 active trials6 approved drugs12 evidence items

NCIt: C3028
MeSH: D004938

Overview
Statistics
Survival
Genomics7
Variants & evidence12
Drugs7
Trials2208
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (90)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 29, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 76–90 of 90 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Identification of symptom clusters and associated factors based on disease characteristics in patients with esophageal cancer undergoing radiotherapy or chemoradiotherapy.
Aijuan Wang, Xiuqin Ren · Front Med (Lausanne) · Jan 1, 2026 · PMID 42780383 · candidate dictionary pubmed
Conjunctival reactive cutaneous capillary endothelial proliferation induced by camrelizumab in an esophageal cancer patient: a case report and literature review.
Yedong Wei, Ying Zan, Jing Zhang et al. · Front Oncol · Jan 1, 2026 · PMID 42798342 · candidate dictionary pubmed
p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
· Ann Surg Oncol · 2010 · PMID 19941080 · validated civic_curation pubmed
The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.
· Oncotarget · 2016 · PMID 27172793 · validated civic_curation pubmed
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
· Pharmacogenomics J · 2009 · PMID 19274060 · validated civic_curation pubmed
Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
· Histopathology · 2010 · PMID 20840671 · validated civic_curation pubmed
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.

Showing 76–90 of 90 publications

← Previous
1
2
3
4
Next →

· Clin Transl Oncol · 2016 · PMID 26459251 · validated civic_curation pubmed

Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis.

· Ann Surg Oncol · 2013 · PMID 23515910 · validated civic_curation pubmed

Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.

· PLoS One · 2016 · PMID 27414035 · validated civic_curation pubmed

Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma.

· BMC Cancer · 2015 · PMID 25924824 · validated civic_curation pubmed

Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification.

· Oncologist · 2020 · PMID 32323889 · validated civic_curation pubmed

The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.

· Mol Cancer Ther · 2012 · PMID 22302096 · validated civic_curation pubmed

Dulak et al. Nat Genet 2013

· 2013 · PMID 23525077 · validated cbioportal_study pubmed

Song et al. Nature 2014

· 2014 · PMID 24670651 · validated cbioportal_study pubmed

Lin et al. Nat Genet 2014

· 2014 · PMID 24686850 · validated cbioportal_study pubmed